Can you shoot methadone pills

Case report: A former heroin abuser presented to the Emergency Department after injecting 10 mg methadone tablets dissolved in water into his femoral artery. He had severe pain and cyanosis of his leg. Laboratory data revealed a creatine kinase CK of Last intravenous consumption was stated to be from 1 to 92 h ago.

Three persons with a reported last intravenous consume 4, 8 and 12 h ago showed negative results. An explanation can be that the statements of the consumers have to be considered as not very reliable.

As told by the staff of the Drob Inn many of them were still intoxicated when they administered their new methadone dose. Therefore, it is not very surprising that not all statements match with the analytical findings. This belongs as well to Person It has to be kept in mind that the reliability of self-reported drug use is limited.

Although our preliminary results with oral ingestion of 20 g sucrose and 20 g lactose in healthy subjects did not give a hint for relevant renal elimination. It has to be taken into account that beside the oral intake of disaccharides by formulations of substitutes additional relevant amounts of sucrose can be ingested by food and beverages. Therefore, we increased the intake of disaccharides in our current control group. Sucrose concentrations of Immunochemical testing was negative for methadone in these cases.

A possible explanation for the detection of sucrose might be a consequence of very high dosed oral intake of sucrose or an increased permeability of the intestinal mucous membrane by non-steroidal anti-inflammatory drugs A reliable cutoff recommendation cannot be given for lactose. Additional characterization of lactose and sucrose in urine and their time profile in larger populations of healthy subjects, patients with a medication of non-steroidal anti-inflammatory drugs, and patients in OMT are indicated before this test can be considered with a reliable cutoff for clinical use.

Results above the cutoff might be a good decision-making basis for the therapist to do a thorough examination of the substituted patient for fresh needle marks.

The above results imply that this is possible. However, there are several limitations to our study. First of all, the time interval of detection is provided only by the drug abusers and cannot be verified.

In two cases four and six , we detected disaccharides 48 and 92 h after last consumption. This is not very likely. In addition, there were only 20 subjects who were willing to provide urine samples. Nevertheless, the reason for this approach was practical. It would not be possible to give sugars intravenously in a clinical study. The intravenous application of highly concentrated sugar solutions is dangerous due to osmotic damage.

Therefore, it was necessary to obtain the samples from persons who consumed these substances of their own free will. Furthermore, it was not easy to find individuals agreeing to provide a urine sample before the consumption of the drug. People visit the consumption room in order to consume their drugs in a protected area.

Their willingness to wait any longer for their intended drug consumption in order to provide samples was rather low. However, the results achieved in this study are in line with the results of 26 other intravenous-consuming subjects who supplied urine samples only one time, 30 min after intravenous consumption.

We think that these results offer enough reasons to use this test in practice. It should be kept in mind that in the case of intestinal diseases like ulcerative colitis or Crohn's disease, this method might not be applicable because the mucosal barrier is inadequate and intact disaccharides can be absorbed from the small intestine after oral ingestion 21 — For this group, the method is not applicable.

Intravenous drug abusers new to OMT have a high risk of intravenously abusing prescribed methadone instead of heroin. It is very difficult for the patients to escape the familiar behavior concerning needles and self-injection It is therefore essential that physicians do not prescribe take-home doses before they are convinced that the substituted patient will use the methadone as intended.

Until now, patients taking part in OMT with take-home doses could not be monitored regarding the administration methods of their substitutes; but information about the route of administration is useful for the attending physicians because it demonstrates whether patients are compliant with the therapy concept. The results show that disaccharides are eliminated for several hours after intravenous consumption. Intravenous use of substitutes is putting patients at risk.

Especially at the beginning of maintenance therapy, it is difficult for patients to avoid familiar patterns related to needles and self-injection. It is therefore helpful for the therapist to know whether patients are compliant with the therapy concept.

With the fast and easy LC—MS-MS method, which can be performed by the majority of laboratories that perform drug testing in urine samples of substituted patients, a helpful tool is available to ensure that the patient is not taking intravenous drugs. Ward , J. Lancet , , — Google Scholar. Humeniuk , R. Addiction Abingdon, England , 98 , — Jensen , S.

International Journal of Legal Medicine , , — Iwersen-Bergmann , S. Waldvogel , D. Musshoff , F. Forensic Science International , , — Judson , G. Drug and Alcohol Review , 29 , 41 — Jungen , H. Journal of Analytical Toxicology , 37 , — Eap , C. Journal of Addictive Diseases , 22 , 7 — Fortschritte Der Neurologie Psychiatrie , 67 , — Darke , S. Drug and Alcohol Dependence , 43 , — Serious breathing problems may be more likely in older adults and people who are debilitated or have wasting syndrome or chronic breathing disorders.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may have a fatal methadone overdose if you start or stop using certain other medicines. Tell your doctor about all your medications.

Many other drugs can be dangerous when used with opioid medicine. Tell your doctor if you also use:. This list is not complete. Many drugs may affect methadone, including prescription and over-the-counter medicines, vitamins, and herbal products.

Not all possible interactions are listed here. Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient.

Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

PeaceHealth endeavors to provide comprehensive health care information, however some topics in this database describe services and procedures not offered by our providers or within our facilities. This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information.

Your use of this information means that you agree to the Terms of Use and Privacy Policy. Learn how we develop our content. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.

Skip to main content. Prisoner leaders, by dictating codes of conduct and determining participation in the obshchak , played a main role in regulating the use of Dimedrol.

When MMT was first introduced in the prison, prisoner leaders noted a sharp increase in Dimedrol-associated deaths and delivered a decree [progon] that banned Dimedrol use, especially by members of the middle prisoner caste [poriadochnye]. When Dimedrol was sold, there were many cases of deaths. After that, they prohibited trading, the sale of Dimedrol.

They had a corpse there each week. One major consequence of the Dimedrol ban is that people who inject Dimedrol must do so furtively. Fears of repercussions cause people to delay seeking care from prison health services for injection-related skin and soft tissue infections:. He shoots Dimedrol. He misses the vein, an abscess forms. You know what that is.

He rots. When there is Dimedrol involved, one cannot function properly, one cannot work, one will just be high. Stigmatization of people who use Dimedrol by other prisoners and members of the informal prison leadership compounded stigmatization of people who accessed MMT.

Because MMT was run by the formal prison authority as opposed to the heroin trade which is run by the informal prison leadership , prisoners receiving MMT were viewed by other prisoners as being aligned with the formal prison authority and viewed suspiciously by the informal prison leaders and other prisoners. Dimedrol is also banned by formal prison administrators, who have their own punitive approach to people in prison using Dimedrol:.

If the guards catch a patient with Dimedrol, a report is immediately drafted…and the patient is locked up in isolation. People on MMT were perceived as being especially vulnerable because they can lose their status in the prison hierarchy. In a prison setting where PWID are vulnerable to exploitation and informal and formal leadership systems compete for control, both MMT and Dimedrol acquire meaning that influence their use and distribution [ 22 ].

These explanations borrowed heavily from a shared sentiment that methadone was harmful and not to be trusted. As one interviewer recorded in his fieldnotes:. Dimedrol is not used on its own and methadone and Dimedrol are often conflated because of how they are used [ 22 ].

The harms of Dimedrol use were attributed to methadone and used as an argument for phasing out methadone:. It actually has a lot to do with methadone because, without methadone, for example, why the hell would anyone need this shit?

It would be better if they were giving heroin that way [as they distribute methadone]. And they would shoot up less Dimedrol. This explicit linking of Dimedrol injection with methadone treatment was evident also in interviews with prison administrators and other non-prisoner participants who acknowledged the difficulty of intervening on Dimedrol injection within Kyrgyz prisons that take a mainly punitive approach to Dimedrol possession.

In this study, we found that Dimedrol injection is a potentially serious drug-related harm among people receiving methadone treatment in Kyrgyz prisons. This study has implications for the further quantitative investigation of antihistamine polysubstance use as well as sociological inquiry into how the relations between different drugs affect the way drugs are used. In the context of a regional rise in HIV incidence primarily associated with injection drug use, our findings suggest that Dimedrol injecting can no longer be ignored as a public health problem.

Dimedrol injection and its health and social consequences were repeatedly raised as areas of concern for MMT implementation by prisoner and non-prisoner participants. In this study, prisoner and non-prisoner participants, including prison administrators and medical staff members, described illicit injection of crushed Dimedrol tablets as a serious and potentially widespread behavioral health concern affecting people receiving methadone treatment in prison.

Participant accounts contain graphic descriptions of disfiguring injuries and behavioral changes consistent with possible effects of diphenhydramine injection described elsewhere [ 17 , 18 , 19 , 20 , 21 ]. Participants pointed to these physical and behavioral changes as evidence that methadone was harmful. Heroin, on the other hand, remained untainted by Dimedrol and therefore is a more favorable substance among prisoners adhering to the rules of criminal subculture.

Prison administrators, medical staff, and community members recognize and have requested support to address the issue but acknowledge long-standing difficulties in controlling the supply of drugs within prison that have contributed to Dimedrol injection and its harmful health consequences in prisons. The narrative that conflates MMT with Dimedrol injecting and its harmful effects [ 22 ] is especially damaging to public health efforts to implement MMT as an intervention for HIV prevention and harm reduction.

Methadone has been a global mainstay of treatment for opioid use disorder for over 40 years. A dose—response curve indicates a minimal dose of 30 mg to prevent symptoms of opioid withdrawal and craving and to effect positive health outcomes, and doses must be individually titrated to reduce the risk of over-sedation and respiratory depression [ 29 ]. Numerous prior studies have suggested that when methadone dosing is inadequate to prevent cravings, polysubstance use prevails and contributes to negative health outcomes [ 30 ].

One possible explanation for Dimedrol injection reported here is that patients are experiencing suboptimal methadone dosing and that prison medical staff should be doing more to screen for concurrent drug use and monitor drug craving in patients receiving methadone. Individuals who use Dimedrol concurrently with MMT often do so intentionally seeking a high, suggesting MMT in the absence of other supportive services or interventions insufficiently manages symptoms of substance use disorders, including impulsivity.

Although people on MMT in Kyrgyz prisons are excluded from heroin distribution, they may use Dimedrol along with MMT to achieve euphoria, combat the boredom inherent to life in prison [ 31 ], or self-medicate mood disorders like depression or anxiety [ 32 ].

Although these motivations were scarcely mentioned by our key informants, they offer a compelling potential explanation for Dimedrol injection in this context and underscore the need for psychiatric care in these settings. One way to curb Dimedrol injecting is by attempting to reduce supply, for example by intervening to reduce delivery of Dimedrol from the outside and creating a climate of health and wellness [ 8 ].

If we are to apply a purely harm reduction lens to the problem of Dimedrol injecting in Kyrgyz prisons, however, then the solution is not to attempt to banish Dimedrol entirely but rather to expand NSP access to support safe injecting practices because many MMT patients are not offered NSP. It is unclear whether crushed Dimedrol tablets, even if mixed with sterile water and injected with sterile equipment, would ever be safe to inject given the seeming toxicity of the substance to veins.

Liquid Dimedrol is not widely available in Kyrgyz prisons and might be more difficult for people to conceal, though theoretically potentially safer to inject. PWID in Kyrgyz prisons need low barrier access to urgent medical services for evaluation and management of skin and soft tissue infections, voluntary and confidential HIV testing, and education about the potential physical and psychological harms of Dimedrol injecting.

None of these interventions will be successful without the buy-in of formal and informal prison leaders, so a major challenge now is to develop and implement these interventions in a way that is meaningful and sustainable given the particularities of criminal subculture in Kyrgyz prisons. Structural interventions are required given how Dimedrol is situated as part of the informal governing and day-to-day survival of people in prison. This study has some limitations.

Most prisoner participants described the behaviors of other prisoners, rather than their own behaviors, which may reflect their lack of comfort in speaking about behaviors that could be construed as deviant or criminal in a prison setting.

Further studies are needed to quantify the frequency of Dimedrol injection and its sequelae, in Kyrgyz prisons and elsewhere. It is likely that antihistamine injecting is more prevalent than reflected in the existing literature because it is legal though banned in prisons and, unlike narcotics, obtained without a prescription.

Although some disclosure about illicit behaviors by people in the prison environment may have been limited by fear of surveillance, we conducted interviews with people in prison at every level of the social hierarchy and people outside of prison in the community where there are fewer potential repercussions of disclosure.

It is unclear how findings would have differed if the interviews were not audio-recorded. Key informant participants and stakeholders were purposively recruited, which may have unintentionally introduced selection bias and limit generalizability to other prisoners or PWID in the EECA, though that was not the intention of this qualitative study [ 33 ].

Finally, most prisoner participants in this study were incarcerated in a male prison. Their views and experiences may differ from those of people incarcerated in a female prison. Some persons receiving methadone treatment in Kyrgyz prisons also may inject crushed Dimedrol tablets, a non-prescription antihistamine that is banned in prison, to achieve a state of euphoria. Dimedrol injection is asserted to cause devastating physical and mental health effects, including psychosis and necrotic injury.

The visible wounds of Dimedrol injection figure prominently in narratives about methadone treatment inside prison. Prisoners who use heroin, which is tightly controlled according to the rules of criminal subculture, do not use Dimedrol, lending heroin a more positive image within prisoner society. The persistence of Dimedrol injection within these settings is a potentially serious threat to individual health and harm reduction within Kyrgyz prisons and elsewhere in EECA region. Walmsley R.

Intersecting epidemics of HIV, HCV, and syphilis among soon-to-be released prisoners in Kyrgyzstan: implications for prevention and treatment.

Int J Drug Policy.